Poster session
Diagnostic and therapeutic nuclear medicine III

Programm

• 14:00 – 14:04 3 Min. 1 Min.

  • Eposter presentation
  • PP25.01

  Automated ⁶⁸Ga-PSMA-PET Total Metabolic Tumor Volume (TMTV) extraction for predicting PSA change in ¹⁷⁷Lu-PSMA therapy

  • Eduardo Ríos Sánchez (Lyon / FR)

   Artificial intelligence, Diagnostic and therapeutic nuclear medicine
• 14:04 – 14:08 3 Min. 1 Min.

  • Eposter presentation
  • PP25.04

  Non-linear mixed-effects modelling for kidneys time-integrated activity determination in [¹⁷⁷Lu]Lu-PSMA-617 therapy

  • Indra Budiansah (Depok / ID)

   Diagnostic and therapeutic nuclear medicine, Radiation protection
• 14:08 – 14:12 3 Min. 1 Min.

  • Eposter presentation
  • PP25.05

  Non-linear mixed-effect modelling including covariate information in [¹⁷⁷Lu]Lu-PSMA-617 therapy

  • Indra Budiansah (Depok / ID)

   Diagnostic and therapeutic nuclear medicine, Radiation protection
• 14:12 – 14:16 3 Min. 1 Min.

  • Eposter presentation
  • PP25.06

  Enhancing image quality in pediatric renal scintigraphy: A path towards dose reduction

  • Ana Margarida Mota (Lisbon / PT)

   Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging
• 14:16 – 14:20 3 Min. 1 Min.

  • Eposter presentation
  • PP25.07

  SPECT/CT system for quantification of [123]I-Ioflupane: A phantom comparison study

  • Dr. Andrea Bettinelli (Padua / IT)

   Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging
• 14:20 – 14:24 3 Min. 1 Min.

  • Eposter presentation
  • PP25.08

  Free breathing CT protocols for attenuation correction in data-driven gating PET/CT techniques

  • Dr. Stefano Carminati (Malgrate / IT)

   Diagnostic and therapeutic nuclear medicine
• 14:24 – 14:28 3 Min. 1 Min.

  • Eposter presentation
  • PP25.09

  Patlak parameters for whole body PET – Analysis of reconstruction stability

  • Gabriel Garcia Ortegon (Munich / DE)

   Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging
• 14:28 – 14:32 3 Min. 1 Min.

  • Eposter presentation
  • PP25.10

  A proposed method for estimation of disease burden in patients with multiple myeloma measured by [¹⁸F]FDG and [¹⁸F]fluciclovine

  • Dr. Johan Blakkisrud (Oslo / NO)

   Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging
• 14:32 – 14:36 3 Min. 1 Min.

  • Eposter presentation
  • PP25.11

  Impact of different algorithms and body mass index in SUV quantification of 18F PET/CT images from two vendors

  • Francesca Bisello (Bologna / IT)

   Diagnostic and therapeutic nuclear medicine
• 14:36 – 14:40 3 Min. 1 Min.

  • Eposter presentation
  • PP25.12

  Comparison of SUV quantification in 68Ga PET/CT images of patient-like phantoms reconstructed with different vendor-specific algorithms

  • Professor Lidia Strigari (Bologna / IT)

   Diagnostic and therapeutic nuclear medicine
• 14:40 – 14:44 3 Min. 1 Min.

  • Eposter presentation
  • PP25.13

  The RATIONALE (RAdionuclide TheragnostIcs for persONALised mEdicine) cost action: State of the art and future prospective

  • Professor Ivo Rausch (Vienna / AT)

   Diagnostic and therapeutic nuclear medicine, Professional matters
• 14:44 – 14:48 3 Min. 1 Min.

  • Eposter presentation
  • PP25.15

  Image reconstruction considerably effects DAT tracer distribution: A preliminary SPECT study in an anatomical brain phantom

  • Dr. Adriano de Maggi (Cuneo / IT)

   Diagnostic and therapeutic nuclear medicine, Innovative radiotherapy and medical imaging